RNA processing modulator

USP1 inhibitors (HR deficient tumor)

Lonafarnib(Zokinvy)

C₂₇H₃₁Br₂ClN₄O₂

CAR macrophage therapy (SIRPalpha deficient, solid tumor)

PD-1 Gene-deficient Activated T Cells

anti-NY-ESO-1 TCR T-cell therapy siTCR (Takara Bio)

Ad5Ag85A

KIR2DL2-deficient CD19-CAR-T cells (H. Lee Moffitt Cancer Center & Research Institute)

Pyruvic acid(Rejuvesol)

C₃H₄O₃

Pozelimab(Veopoz)